Biomarkers in Heart Failure Clinical Insights

被引：11
作者：
Salzano, Andrea [1 ]
D'Assante, Roberta [2 ]
Israr, Muhammad Zubair [3 ]
Eltayeb, Mohamed [3 ]
D'Agostino, Anna [1 ]
Bernieh, Dennis [3 ]
De Luca, Mariarosaria [2 ]
Rega, Salvatore [2 ]
Ranieri, Brigida [1 ]
Mauro, Ciro [4 ]
Bossone, Eduardo [4 ]
Squire, Iain B. [3 ]
Suzuki, Toru [3 ]
Marra, Alberto M. [2 ]
机构：
[1] IRCCS SDN Nucl & Diagnost Res Inst, Via E Gianturco 113, I-80143 Naples, Italy
[2] Univ Naples Federico II, Dept Translat Med Sci, Naples, Italy
[3] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England
[4] AORN A Cardarelli, Cardiac Rehabil Unit, Naples, Italy
来源：
HEART FAILURE CLINICS | 2021年 / 17卷 / 02期
关键词：
Biomarkers; Heart failure; Prognosis; Risk stratification; Outcomes; Diagnosis; VENTRICULAR SYSTOLIC DYSFUNCTION; BRAIN-NATRIURETIC PEPTIDE; TRIMETHYLAMINE-N-OXIDE; SENSITIVITY TROPONIN-T; GUIDED THERAPY; CARDIOVASCULAR MORTALITY; RISK STRATIFICATION; COLLABORATIVE CARE; COST-EFFECTIVENESS; EJECTION FRACTION;
D O I：
10.1016/j.hfc.2021.01.002
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：223 / 243
页数：21
相关论文
共 195 条
[1]  
AIMO A, 2019, CIRCULATION, V74, P2193
[2]   Circulating levels and prognostic value of soluble ST2 in heart failure are less influenced by age than N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T [J].
Aimo, Alberto ;
Januzzi, James L., Jr. ;
Vergaro, Giuseppe ;
Richards, A. Mark ;
Lam, Carolyn S. P. ;
Latini, Roberto ;
Anand, Inder S. ;
Cohn, Jay N. ;
Ueland, Thor ;
Gullestad, Lars ;
Aukrust, Pal ;
Brunner-La Rocca, Hans-Peter ;
Bayes-Genis, Antoni ;
Lupon, Josep ;
de Boer, Rudolf A. ;
Takeishi, Yasuchika ;
Egstrup, Michael ;
Gustafsson, Ida ;
Gaggin, Hanna K. ;
Eggers, Kai M. ;
Huber, Kurt ;
Gamble, Greg D. ;
Ling, Lieng H. ;
Leong, Kui Tong Gerard ;
Yeo, Poh Shuah Daniel ;
Ong, Hean Yee ;
Jaufeerally, Fazlur ;
Ng, Tze P. ;
Troughton, Richard ;
Doughty, Robert N. ;
Passino, Claudio ;
Emdin, Michele .
EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (11) :2078-2088
[3]  
ARBIT B, 2016, HEART FAIL CLIN, V13, P1310
[4]  
ARCOPINTO M, 2015, EUR J ENDOCRINOL, V30, P277
[5]  
ARCOPINTO M, 2013, J AM COLL CARDIOL, V113, P76
[6]   Growth Hormone Deficiency Is Associated with Worse Cardiac Function, Physical Performance, and Outcome in Chronic Heart Failure: Insights from the TOSCA. GHD Study [J].
Arcopinto, Michele ;
Salzano, Andrea ;
Giallauria, Francesco ;
Bossone, Eduardo ;
Isgaard, Joergen ;
Marra, Alberto M. ;
Bobbio, Emanuele ;
Vriz, Olga ;
Aberg, David N. ;
Masarone, Daniele ;
De Paulis, Amato ;
Saldamarco, Lavinia ;
Vigorito, Carlo ;
Formisano, Pietro ;
Niola, Massimo ;
Perticone, Francesco ;
Bonaduce, Domenico ;
Sacca, Luigi ;
Colao, Annamaria ;
Cittadini, Antonio .
PLOS ONE, 2017, 12 (01)
[7]   Multiple hormone deficiencies in chronic heart failure [J].
Arcopinto, Michele ;
Salzano, Andrea ;
Bossone, Eduardo ;
Ferrara, Francesco ;
Bobbio, Emanuele ;
Sirico, Domenico ;
Vriz, Olga ;
De Vincentiis, Carlo ;
Matarazzo, Margherita ;
Saldamarco, Lavinia ;
Sacca, Francesco ;
Napoli, Raffaele ;
Lacoviello, Massimo ;
Triggiani, Vincenzo ;
Isidori, Andrea M. ;
Vigorito, Carlo ;
Isgaard, Jorgen ;
Cittadini, Antonio .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 184 :421-423
[8]  
ARROYO AB, 2018, JAMA-J AM MED ASSOC, V38, P892
[9]   N-terminal fraction of pro-B-type natriuretic peptide versus clinical risk scores for prognostic stratification in chronic systolic heart failure [J].
Arzilli, Chiara ;
Aimo, Alberto ;
Vergaro, Giuseppe ;
Ripoli, Andrea ;
Senni, Michele ;
Emdin, Michele ;
Passino, Claudio .
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2018, 25 (08) :889-895
[10]   Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework [J].
Atkinson, AJ ;
Colburn, WA ;
DeGruttola, VG ;
DeMets, DL ;
Downing, GJ ;
Hoth, DF ;
Oates, JA ;
Peck, CC ;
Schooley, RT ;
Spilker, BA ;
Woodcock, J ;
Zeger, SL .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (03) :89-95
12345678910